Duygu Gezen‐Ak

The interleukin 1 alpha, interleukin 1 beta, interleukin 6 and alpha-2-macroglobulin serum levels in patients with early or late onset Alzheimer's disease, mild cognitive impairment or Parkinson's disease

Erdinç Dursun, Duygu Gezen‐Ak, Haşmet Hanağası et al. · Journal of Neuroimmunology · 2015 · 230 citations

Medicine, Immunology, Neurology +17

BDNF, TNFα, HSP90, CFH, and IL-10 Serum Levels in Patients with Early or Late Onset Alzheimer's Disease or Mild Cognitive Impairment

Duygu Gezen‐Ak, Erdinç Dursun, Haşmet Hanağası et al. · Journal of Alzheimer s Disease · 2013 · 185 citations

Life Sciences, Neurology, Neuroscience +17

A Novel Perspective for Alzheimer's Disease: Vitamin D Receptor Suppression by Amyloid-β and Preventing the Amyloid-β Induced Alterations by Vitamin D in Cortical Neurons

Erdinç Dursun, Duygu Gezen‐Ak, Selma Yılmazer · Journal of Alzheimer s Disease · 2011 · 170 citations

Medicine, Neurobiology, Neuroscience +17

Association between Vitamin D Receptor Gene Polymorphism and Alzheimer's Disease

Duygu Gezen‐Ak, Erdinç Dursun, Turan Ertan et al. · The Tohoku Journal of Experimental Medicine · 2007 · 145 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

The Effects of Vitamin D Receptor Silencing on the Expression of LVSCC-A1C and LVSCC-A1D and the Release of NGF in Cortical Neurons

Duygu Gezen‐Ak, Erdinç Dursun, Selma Yılmazer · PLoS ONE · 2011 · 128 citations · Full text

Medicine, Neurobiology, Neuroscience +17